Fig. 6From: Mammalian enabled protein enhances tamoxifen sensitivity of the hormone receptor-positive breast cancer patients by suppressing the AKT signaling pathwayMENA knockdown promotes tamoxifen resistance in the HR+ breast cancer cells via AKT signaling pathway. Western blot analysis shows MENA, AKT, p-AKT (Ser473) and β-actin protein levels in the control and MENA-silenced T47D and MCF7 treated with or without 4-OHT cellsBack to article page